Peripheral & Cranial Nerve Stimulation

Deep-brain stimulators have to drill through the skull, carry real risk, and grow slowly. But there's a smarter side — instead of going all the way into the brain, it taps the nervous system's "cables" as they pass through the neck, under the tongue, or in the pelvis. Easier to operate, lower risk, and it opens the door to diseases that millions of people have. The rising star is the hypoglossal-nerve stimulator that treats sleep apnea — already over $900 million a year in revenue. And in 2025, a single vagus nerve was approved by the FDA to treat rheumatoid arthritis for the first time, opening the era of "bioelectronic medicine."

Peripheral & Cranial Nerve Stimulation▲

Brain Implants Market to Reach USD 18.39 Billion by 2035, Growing at 9.99% CAGR

The global brain implants market is projected to grow from USD 7.10 billion in 2025 to USD 18.39 billion by 2035, expanding at a compound annual growth rate of 9.99 percent, according to a new report by SNS Insider. North America held the largest share in 2025, with the U.S. market alone valued at approximately USD 3.16 billion and expected to reach USD 8.17 billion by 2035. The deep brain stimulators segment accounted for about 37.6 percent of total revenue in 2025, while Parkinson's disease represented the largest application segment at roughly 34.3 percent. The Asia-Pacific region is forecast to be the fastest-growing market, driven by rising neurological disease prevalence and expanding neurosurgical infrastructure.

Brain-Computer Interface ▲

GlobeNewswire·83dRead more →